Legend Biotech Corp (LEGN)
45.18
-1.19
(-2.57%)
USD |
NASDAQ |
May 17, 16:00
45.18
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Revenue (Quarterly): 93.99M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 93.99M |
| December 31, 2023 | 79.46M |
| September 30, 2023 | 96.01M |
| June 30, 2023 | 73.33M |
| March 31, 2023 | 36.34M |
| December 31, 2022 | 27.63M |
| September 30, 2022 | 27.36M |
| June 30, 2022 | 11.97M |
| March 31, 2022 | 50.04M |
| December 31, 2021 | 18.03M |
| September 30, 2021 | 16.88M |
| Date | Value |
|---|---|
| June 30, 2021 | 20.23M |
| March 31, 2021 | |
| December 31, 2020 | 40.11M |
| September 30, 2020 | 11.75M |
| June 30, 2020 | 11.60M |
| March 31, 2020 | 11.55M |
| December 31, 2019 | 19.45M |
| September 30, 2019 | 17.67M |
| June 30, 2019 | 10.09M |
| March 31, 2019 | 10.05M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
10.09M
Minimum
Jun 2019
96.01M
Maximum
Sep 2023
35.45M
Average
20.23M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Johnson & Johnson | 21.38B |
| Bristol-Myers Squibb Co | 11.86B |
| 2seventy bio Inc | 12.44M |
| Exelixis Inc | 425.23M |
| Fortrea Holdings Inc | 662.10M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.79M |
| Total Expenses (Quarterly) | 211.24M |
| EPS Diluted (Quarterly) | -0.32 |
| Enterprise Value | 7.216B |
| Gross Profit Margin (Quarterly) | 41.76% |
| Profit Margin (Quarterly) | -63.62% |
| Earnings Yield | -5.71% |
| Normalized Earnings Yield | -5.021 |